OBJECTIVE: We sought to assess the usefulness of clinical, biophysical, and biochemical
tests in the prediction of preeclampsia. DATA SOURCES: The sources of data we used to …

Antiphospholipid antibodies (aPL) can be detected by functional (lupus anticoagulant)
and/or by solid phase assays (anti-cardiolipin and anti-beta2 glycoprotein I). Although …

New clinical, laboratory and experimental insights, since the 1999 publication of the
Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been …

Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based …

BACKGROUND: The association between antiphospholipid antibodies (APLA) and placenta
mediated pregnancy complications (pre-eclampsia, intrauterine growth restriction (IUGR) …

There are multiple epidemiological studies that document the potential adverse affects of
autoimmunity on nearly every aspect of reproduction, even in the absence of clinically …

Pregnancy morbidity is one of the clinical manifestations used for classification criteria of
antiphospholipid syndrome (APS). During the 14th International Congress on …

Background: Women with familial thrombophilia have an increased risk of still birth. We
postulated that the presence of asymptomatic risk factors for venous thrombosis might be a …

BACKGROUND Antiphospholipid antibodies (aPL) are a family of auto-antibodies that are
associated with an increased risk of recurrent miscarriage, intrauterine growth restriction and …

METHODS OF STUDY SELECTION: Inclusion criteria were: cohorts, case-control, or
controlled cross-sectional studies; healthy pregnancy as controls; no autoimmune diseases; …